Skip to main content
SpringerLink
Log in

GlaxoSmithKline (GSK) have asked government healthcare officials from several nations for opinions on which investigational drugs should be prioritised

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Wall Street Journal.Glaxo seeks guidance from health systems. Internet Document: [3 pages], 7 Jul 2008. Available from: URL: http://online.wsj.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

GlaxoSmithKline (GSK) have asked government healthcare officials from several nations for opinions on which investigational drugs should be prioritised. Pharmacoecon. Outcomes News 558, 10 (2008). https://doi.org/10.2165/00151234-200805580-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805580-00027

Keywords

Search

Navigation